| The sequence of the human genome JC Venter, MD Adams, EW Myers, PW Li, RJ Mural, GG Sutton, HO Smith, ... science 291 (5507), 1304-1351, 2001 | 20172 | 2001 |
| The Genome Sequence of Drosophila melanogaster MD Adams, SE Celniker, RA Holt, CA Evans, JD Gocayne, ... Science 287 (5461), 2185-2195, 2000 | 8193 | 2000 |
| The Genome Sequence of the Malaria Mosquito Anopheles gambiae RA Holt, GM Subramanian, A Halpern, GG Sutton, R Charlab, ... science 298 (5591), 129-149, 2002 | 2546 | 2002 |
| A Whole-Genome Assembly of Drosophila EW Myers, GG Sutton, AL Delcher, IM Dew, DP Fasulo, MJ Flanigan, ... Science 287 (5461), 2196-2204, 2000 | 2125 | 2000 |
| Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M KS Thress, CP Paweletz, E Felip, BC Cho, D Stetson, B Dougherty, Z Lai, ... Nature medicine 21 (6), 560-562, 2015 | 1513 | 2015 |
| VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research Z Lai, A Markovets, M Ahdesmaki, B Chapman, O Hofmann, R McEwen, ... Nucleic acids research 44 (11), e108-e108, 2016 | 763 | 2016 |
| Comparative Genome and Proteome Analysis of Anopheles gambiae and Drosophila melanogaster EM Zdobnov, C Von Mering, I Letunic, D Torrents, M Suyama, RR Copley, ... science 298 (5591), 149-159, 2002 | 608 | 2002 |
| Chromosome 2 Sequence of the Human Malaria Parasite Plasmodium falciparum MJ Gardner, H Tettelin, DJ Carucci, LM Cummings, L Aravind, EV Koonin, ... Science 282 (5391), 1126-1132, 1998 | 582 | 1998 |
| A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome RJ Mural, MD Adams, EW Myers, HO Smith, GLG Miklos, R Wides, ... Science 296 (5573), 1661-1671, 2002 | 485 | 2002 |
| Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells H Dev, TWW Chiang, C Lescale, I de Krijger, AG Martin, D Pilger, ... Nature cell biology 20 (8), 954-965, 2018 | 353 | 2018 |
| Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study SM Domchek, S Postel-Vinay, SA Im, YH Park, JP Delord, A Italiano, ... The Lancet Oncology 21 (9), 1155-1164, 2020 | 330 | 2020 |
| Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models CA Eberlein, D Stetson, AA Markovets, KJ Al-Kadhimi, Z Lai, PR Fisher, ... Cancer research 75 (12), 2489-2500, 2015 | 317 | 2015 |
| Human chromosome 7: DNA sequence and biology SW Scherer, J Cheung, JR MacDonald, LR Osborne, K Nakabayashi, ... Science 300 (5620), 767-772, 2003 | 268 | 2003 |
| Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes DR Hodgson, BA Dougherty, Z Lai, A Fielding, L Grinsted, S Spencer, ... British journal of cancer 119 (11), 1401-1409, 2018 | 205 | 2018 |
| Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1 J Wu, K Mikule, W Wang, N Su, P Petteruti, F Gharahdaghi, E Code, X Zhu, ... ACS chemical biology 8 (10), 2201-2208, 2013 | 161 | 2013 |
| Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol J Wu, F Powell, NA Larsen, Z Lai, KF Byth, J Read, RF Gu, M Roth, ... ACS chemical biology 8 (3), 643-650, 2013 | 157 | 2013 |
| The combination of the PARP inhibitor olaparib and the WEE1 inhibitor AZD1775 as a new therapeutic option for small cell lung cancer A Lallo, KK Frese, CJ Morrow, R Sloane, S Gulati, MW Schenk, F Trapani, ... Clinical Cancer Research 24 (20), 5153-5164, 2018 | 146 | 2018 |
| Long-term responders on olaparib maintenance in high-grade serous ovarian cancer: clinical and molecular characterization S Lheureux, Z Lai, BA Dougherty, S Runswick, DR Hodgson, KM Timms, ... Clinical Cancer Research 23 (15), 4086-4094, 2017 | 133 | 2017 |
| A shotgun optical map of the entire Plasmodium falciparum genome Z Lai, J Jing, C Aston, V Clarke, J Apodaca, ET Dimalanta, DJ Carucci, ... nature genetics 23 (3), 309-313, 1999 | 132 | 1999 |
| Defining actionable mutations for oncology therapeutic development TH Carr, R McEwen, B Dougherty, JH Johnson, JR Dry, Z Lai, Z Ghazoui, ... Nature Reviews Cancer 16 (5), 319-329, 2016 | 112 | 2016 |
